Breaks Categories: News

FridayAug 16, 2024 9:42 am

NetworkNewsBreaks – Starco Brands Inc. (STCB) Board Approves Insider Trading Policy, Shares Plans to Buy Back Stock

Starco Brands (OTCQB: STCB), a developer and acquirer of behavior-changing technologies and brands that spark excitement in the everyday, has announced approval by its board of the company’s Insider Trading Policy and plans for insiders to buy-back stock. The announcement noted that all five of the company’s portfolio brands have seen year-to-date growth, with two of the divisions expected to double year over year through 2024. “As our public company continues to grow and gain in popularity, the employees and senior executives are eager to own more of our stock,” said Starco Brands chair and CEO Ross Sklar in the…

Continue Reading

ThursdayAug 15, 2024 3:05 pm

NetworkNewsBreaks – MetAlert Inc. (MLRT) Receives GPS SmartSoles PO from Mexico-Based Security Solutions Provider

MetAlert (OTC: MLRT), a pioneer in GPS wearable technology and global provider in the field of human and asset-tracking and recovery systems, has received an initial order for GPS SmartSoles(R) from Skyangel Security headquartered in Mexico City, Mexico. According to the announcement, the partnership with Skyangle, a company committed to providing top-tier security solutions across North and Central America, could lead to strengthening and expanding the SmartSole market share in the Mexico and Latin America security space. The company also noted that SmartSole trials are being conducted in Spain, Portugal and the Netherlands, with plans for the company to launch…

Continue Reading

ThursdayAug 15, 2024 2:45 pm

NetworkNewsBreaks – PayPal Holdings Inc. (NASDAQ: PYPL) Upgraded to Outperform by Daiwa Capital Markets

Daiwa Capital Markets has recently shifted its stance on PayPal Holdings (NASDAQ: PYPL), upgrading the stock to Outperform from Neutral. This move indicates a stronger belief in PayPal’s potential to excel within the competitive fintech sector. PayPal, a leading digital payments platform, has been at the forefront of the financial technology revolution, offering a wide range of services that facilitate online payments for consumers and businesses alike. This upgrade by Daiwa Capital Markets suggests that analysts are becoming increasingly optimistic about PayPal’s strategic position and its ability to capitalize on growth opportunities. The upgrade comes at a time when PayPal’s stock…

Continue Reading

ThursdayAug 15, 2024 2:40 pm

NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Announces Completion of Name Change, Begins Trading Under New Symbol

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM), formerly FSD Pharma Inc., a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, has finalized its previously announced name change and consolidation. According to the announcement, the company’s class B subordinate voting shares began trading today under the new ticker symbol QNTM. In addition, the company closed on a nonbrokered private placement and issued four postconsolidation Class A multiple voting shares for $18 per share, resulting in gross proceeds of $72. Xorax Family Trust, a trust of which Quantum BioPharma CEO and cochair Zeeshan Saeed is a beneficiary,…

Continue Reading

ThursdayAug 15, 2024 1:51 pm

NetworkNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF), American West Metals Report ‘Excellent Results’ from Ongoing Drilling at Storm Project

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), a mineral exploration company exploring for high-grade critical and precious metal deposits in Nunavut, Canada, and Virginia, USA, and American West Metals Limited today provided an update on drilling activities at the Storm Copper Project on Somerset Island, Nunavut. According to the update, the resource delineation program is on track with multiple high-grade copper intervals confirmed by assays at the Cyclone and Chinook Deposits. Additionally, the drill program continues to achieve milestones; a total of 100 Reverse Circulation (“RC”) drill holes and 12 diamond drill holes totaling over 15,500 meters have been completed at…

Continue Reading

ThursdayAug 15, 2024 1:47 pm

NetworkNewsBreaks – Actuate Therapeutics, Inc. (NASDAQ: ACTU) Closes on $22.4M Initial Public Offering

Actuate Therapeutics (NASDAQ: ACTU), a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers, recently announced the closing of its previously announced initial offering. The offering comprised 2,800,000 shares of the company’s common stock at a price of $8.00 per unit to the public, raising a total of $22,400,000 in gross proceeds before deductions. In addition, the company has granted a 30-day option to the underwriters to purchase up to 420,000 additional shares, representing 15% of the shares sold in the offering, solely to cover over-allotments, if any, at the initial…

Continue Reading

ThursdayAug 15, 2024 1:30 pm

NetworkNewsBreaks – Software Effective Solutions Corp. (SFWJ) to Eliminate $450,000 of Convertible Debt by the End of Q3

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana), a holding company focused on the cannabis and agricultural technology sectors, today announced that all convertible debt on its balance sheet amounting to $450,000 will be eliminated by the end of the third quarter. “Our goal is to build a strong company focusing on revenue and, most importantly, enhanced shareholder value. We want our shareholders to invest with confidence, knowing they will not have to worry about any debt conversion hindering the value of their shares,” said Gabriel Diaz, CEO of MedCana. To view the full article, visit https://nnw.fm/Tx8Ay About Software Effective Solutions…

Continue Reading

ThursdayAug 15, 2024 12:29 pm

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Releases Q2 2024 Financial Report, Operational Update

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, is reporting on financial and operations results for its second quarter 2024, the period that ended June 30, 2024. Highlights of the report include steady progress made toward key clinical and regulatory milestones on its HeartBeam AIMIGo(TM) System, including the 510(k) submission to the U.S. Food and Drug Administration (FDA); the report also noted that the company has completed two presubmission meetings with the FDA regarding the company’s planned 510(k) submission of its 12-lead synthesis software. “The second quarter of 2024 was…

Continue Reading

ThursdayAug 15, 2024 12:05 pm

NetworkNewsBreaks – Golden Triangle Ventures Inc. (GTVH), Saxon Capital Group Partner to Bring ‘Groundbreaking’ Solar Glass Technology to Destino Ranch

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, today announced a strategic partnership with Saxon Capital Group Inc. (OTC: SCGX). As part of the partnership, SCGX will utilize and integrate its revolutionary Energy Glass Solar(TM) technology across the entirety of GTVH’s highly anticipated Destino Ranch project. Energy Glass Solar(TM) is a patented, optically clear photovoltaic window system that generates continuous electricity from sunlight, diffused, and ambient light. It is an ideal solution for Destino Ranch, offering numerous advantages. “We are thrilled to partner with Saxon Capital Group to bring their groundbreaking solar glass technology to Destino Ranch. This partnership…

Continue Reading

ThursdayAug 15, 2024 11:51 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Publishes Q2 2024 Results

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today released its financial results for the second quarter ended June 30, 2024 (“Q2 2024”). The company also discussed the clinical development progress of Berubicin, its lead program, and TPI 287, its recently in-licensed abeotaxane for the treatment of brain malignancies. CNS Pharmaceutical expects to be able to release final topline data from its potentially pivotal trial of Berubicin in the first half of 2025. The trial is evaluating Berubicin in adult patients with…

Continue Reading